Latest news
Loading news…
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
18
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- London, England, United Kingdom
Acquisitions by Epsilogen
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Epsilogen
Chief Scientific Officer
Chief Medical Officer
Chief Business Officer
CEO
18
professional contacts at Epsilogen
Contact execs at Epsilogen →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Epsilogen
Loading news…
FAQs about Epsilogen
People who checked this page also checked these
Sectors Epsilogen invests & acquires in
Browse the full Acquirezy directory.